Sawyer P N, Dowbak G, Sophie Z, Feller J, Cohen L
Surgery. 1979 Feb;85(2):201-4.
A randomized trial involving 50 patients has demonstrated that a new type of debriding agent, cross-linked dextran beads with the trade name Debrisan (dextranomer, Pharmacia, Inc.), will produce rapid healing of cutaneous ulcers which have been resistant to conventional therapy over the long-term. Evaluation in terms of a number of therapeutic parameters, including rate of healing, dehydration, sterilization, loss of symptoms, and improvement in physiology, is included in this preliminary study.
一项涉及50名患者的随机试验表明，一种新型清创剂——商品名为Debrisan（葡聚糖聚合物，法玛西亚公司）的交联葡聚糖珠，将使长期以来对传统疗法有抗性的皮肤溃疡迅速愈合。这项初步研究包括了从多个治疗参数方面进行评估，这些参数包括愈合速度、脱水情况、杀菌情况、症状消失情况以及生理机能的改善情况。
